Form 4 for MEDS DataMeds AI, Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-21 · accession 0001641172-25-000584 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-21 | MEDS | AJJARAPU SURENDRA K | Dir | A - Grant | $0.00 | +2.88M | 1.82M | New | $0 | |
| MI | 2025-03-25 | 2025-03-21 | MEDS | AJJARAPU SURENDRA K | Dir | A - Grant | $0.00 | +1.20M | 4.46M | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 2,882,247 | $0.00 | 1,822,247 | D By the Sandhya Ajjarapu Revocable Trust 2007 | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. |
| 2 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 600,000 | $0.00 | 3,100,000 | I | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. |
| 3 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 600,000 | $0.00 | 4,463,200 | I By Sansur Associates LLC | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. |